This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
FuelCell Energy, Inc. (FCEL - Free Report) has announced to increase its annual production from current 25 megawatts (MW) to 55MW, representing a rise of 120% in production rate. Also, the ramped-up production will add nearly 100 manufacturing jobs at its Torrington, CT manufacturing facility. The company undertook an expansion plan last year with two projects totaling 22.2MW, which has further provided it with the much-needed visibility to commence hiring and boost the production going forward.
GLO GTMEY FCELB GTMEF OXY GLOPP PLUG GLOPA FCEL BLDP
Ballard Power Systems (BLDP - Free Report) has announced that its unit Protonex has received a $1.0 million order to supply SPM-622 Squad Power Manager Kits to support U.S. Army brigades deploying overseas. The waterproof SPM-622 Squad Power Manager works as a universal power hub and automatic voltage converter, lowering battery burden and supporting missions in harsh environment. The SPM-622 Squad Power Manager system’s ability to convert and manage the power that the unit is drawing or passing through makes it unique and helps today’s warfighter to manage energy between batteries and electronic equipment.
BLD VPG.WI IEC SRI BLDP VPG
Document UNITED STATES
At Today's Smart Shipping Symposium hosted by the City of Glasgow College Faculty of Nautical Studies, Jim McColl OBE, Chairman and Chief Executive of Clyde Blowers Capital announced that Port Glasgow-based Ferguson Marine Engineering Limited has successfully led a European consortium in a bid for EU funding support to pave the way for the building and launch of the world's first sea-going car and passenger ferry fuelled by Hydrogen.
MCPHY MPHYF BLDP
FuelCell Energy Inc (FCEL - Free Report) was awarded two fuel cell projects by the Connecticut Department of Energy & Environmental Protection (“DEEP”) after successful bidding. The 22.2-Megawatts (MW) energy projects include a 14.8-MW project in Derby and 7.4-MW project in Hartford. These projects will provide clean power, grid resiliency benefits and renewable energy credits to the Connecticut utilities under the 20-year power purchase agreements.
SPG.PRJ GM.WS.A GM.WS.B FCELB GM.WS.C SPG GM GM.WSB PLUG FCEL BLDP
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to BLDP / Ballard Power Systems, Inc. on message board site Silicon Investor.
|Ballard Power -world leader zero-emission PEM fuel cells||Ballard Power (BLDPF) - The Holy Grail|
as of ET